cardiovascular-agents and Gout

Topics: Cardiovascular Agents; Comorbidity; Gout; Gout Suppressants; Heart Failure; Humans; Risk Factors; Uric Acid

Topics: Cardiovascular Agents; Gout; Humans; Incidence; Uricosuric Agents

Under observation were 40 hypertensive patients with coronary heart disease, gout and obesity I and II degree. Patients with hypertension in combination with coronary heart disease, gout and obesity, syndrome of early vascular aging is shown by increased stiffness of arteries, increased peak systolic flow velocity, pulse blood presure, the thickness of the intima-media complex, higher level endotelinemia and reduced endothelial vasodilation. Obtained evidence that losartan in complex combination with basic therapy and metamaks in complex combination with basic therapy positively affect the elastic properties of blood vessels and slow the progression of early vascular aging syndrome.

Topics: Antihypertensive Agents; Blood Flow Velocity; Blood Pressure; Cardiovascular Agents; Carotid Arteries; Coronary Disease; Elasticity; Endothelium, Vascular; Female; Gout; Humans; Hypertension; Losartan; Male; Methylhydrazines; Middle Aged; Obesity; Severity of Illness Index; Tunica Intima; Tunica Media; Vascular Stiffness

Topics: Cardiovascular Agents; Gout; Muscle Relaxants, Central; Zoxazolamine

Topics: Animals; Behavior, Animal; Cardiovascular Agents; Ergot Alkaloids; Gout; Peripheral Vascular Diseases; Social Behavior; Vascular Diseases